Skip to main content

Advertisement

Log in

Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension

  • Sleep Breathing Physiology and Disorders • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Purpose

Sleep disturbance is common in patients with advanced interstitial lung disease (ILD) often complicated by pulmonary hypertension (PH) and may contribute to poor quality of life. The etiology of sleep disturbance and the relationship between PH and sleep architecture in patients with ILD remains unknown.

Methods

We performed a retrospective cohort study comparing sleep architecture on polysomnography in patients with ILD with and without PH, defined as mean pulmonary artery pressure on right heart catheterization ≥ 20 mmHg. We tested the hypothesis that patients with ILD and PH would have increased wake time after sleep onset (WASO) compared to patients with ILD without PH using univariate analysis and multivariable linear regression.

Results

In our cohort of patients with ILD who underwent polysomnography (N = 49), patients with PH had lower total diffusion capacity for carbon monoxide (DLCO) (9.28 vs. 12.87 ml/min/mmHg, P = 0.04) and percent DLCO (39% vs. 53%, P = 0.03). On polysomnography, patients with PH had increased percentage of total sleep time with saturation < 90% (T90) (17% vs. 6%, P = 0.03), decreased N2 sleep (181 vs. 233 min, P = 0.03), decreased %N2 sleep (59% vs. 66%, P = 0.04), increased %N1 sleep (22% vs. 14%, P = 0.02), decreased sleep efficiency (62% vs. 72%, P = 0.03), and increased WASO (133 vs. 84 min, P = 0.01). In multivariable analysis, PH was associated with a 43-min increase in WASO (95% CI 6.2–80.2, P = 0.02).

Conclusion

Patients with ILD and PH have decreased total and %N2 sleep, increased %N1 sleep, decreased sleep efficiency, and increased WASO, likely indicating increased sleep fragmentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Availability of data and material

Raw data is available at request.

Code availability

Not applicable.

References

  1. Mermigkis C, Bouloukaki I, Schiza SE (2017) Sleep as a new target for improving outcomes in idiopathic pulmonary fibrosis. Chest 152(6):1327–1338

    Article  PubMed  Google Scholar 

  2. Myall KJ, West A, Kent BD (2019) Sleep and interstitial lung disease. Curr Opin Pulm Med 25(6):623–628

    Article  PubMed  Google Scholar 

  3. Khor YH, Ryerson CJ, Landry SA, et al (2021) Interstitial lung disease and obstructive sleep apnea. Sleep Med Rev 58:101442

  4. Mermigkis C, Stagaki E, Amfilochiou A, et al (2009) Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. Med Princ Pract 18(1):10–15

    Article  CAS  PubMed  Google Scholar 

  5. Simonneau G, Montani D, Celermajer DS, et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53(1):1801913

  6. Perez-Padilla R, West P, Lertzman M, Kryger MH (1985) Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis 132(2):224–229

    CAS  PubMed  Google Scholar 

  7. Mermigkis C, Bouloukaki I, Antoniou K et al (2015) Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath 19(1):385–391

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Data collection and analysis were performed by Joseph L. Simonson, Dhwani Panyda, and Sarah Khan. The manuscript was written by Joseph L. Simonson and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Joseph L. Simonson.

Ethics declarations

Ethics approval

Approval for this retrospective study was obtained from the institutional review board of Northwell Health, which waived the need to obtain informed consent from subjects. The research was conducted in accordance with the Declaration of Helsinki.

Consent to participate

The need for informed consent was waived by the institutional review board.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simonson, J.L., Pandya, D., Khan, S. et al. Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension. Sleep Breath 26, 1711–1715 (2022). https://doi.org/10.1007/s11325-021-02555-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-021-02555-1

Keywords

Navigation